scispace - formally typeset
R

Roger S. Blumenthal

Researcher at Johns Hopkins University

Publications -  828
Citations -  50648

Roger S. Blumenthal is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 94, co-authored 746 publications receiving 40461 citations. Previous affiliations of Roger S. Blumenthal include Johns Hopkins University School of Medicine & Houston Methodist Hospital.

Papers
More filters
Journal ArticleDOI

Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.

TL;DR: In this paper, multiple studies have attempted to identify the association between multivitamin/mineral (MVM) supplementation and cardiovascular disease (CVD) outcomes, but the benefits remain controv...
Journal ArticleDOI

Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individuals

TL;DR: Adding family history, obesity, and physical inactivity to traditional risk assessment improves prediction of advanced CAC, which may lead these individuals to be treated more aggressively at an earlier age.
Journal ArticleDOI

Risk and the Physics of Clinical Prediction

TL;DR: Shifting the focus from prediction of events to detection of disease could improve personalized decision-making and outcomes and also discuss innovative future strategies for risk estimation and treatment allocation in preventive cardiology.
Journal ArticleDOI

Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method

TL;DR: In a nationally representative sample, a hospital laboratory, and a reference laboratory, approximately one-fifth of individuals with Friedewald-estimated LDL-C <70 mg/dL have a value ≥70 mg/dL using the novel cholesterol equation, which may lead to the misclassification of high-risk individuals and subsequent under- utilization of lipid-lowering therapies.